No Data
No Data
Okyo Pharma Announces FDA Granted FTD to Urcosimod
OKYO Pharma CEO Discusses FDA Fast Track Filing for Urcosimod - ICYMI | NASDAQ:OKYO
Small Cap Wrap: OKYO Pharma, Charbone Hydrogen, Hillcrest...
OKYO Pharma Reports Long-term Benefits of Its Neuropathic Corneal Pain Treatment
OKYO Pharma Announces Positive Data in Long-Term Stability of Urcosimod
OKYO Pharma Files For Fast Track Designation With FDA For Urcosimod To Treat Neuropathic Corneal Pain